L
Liang Zeng
Publications - 19
Citations - 1408
Liang Zeng is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications receiving 1209 citations.
Papers
More filters
Journal ArticleDOI
The genome of the pear (Pyrus bretschneideri Rehd.)
Jun Wu,Zhiwen Wang,Zebin Shi,Shu Zhang,Ray Ming,Shilin Zhu,M. Awais Khan,Shutian Tao,Schuyler S. Korban,Hao Wang,Nancy Jung Chen,Takeshi Nishio,Xun Xu,Lin Cong,Kaijie Qi,Xiaosan Huang,Wang Yingtao,Xiang Zhao,Juyou Wu,Cao Deng,Caiyun Gou,Weili Zhou,Hao Yin,Qin Gaihua,Yuhui Sha,Ye Tao,Hui Chen,Ya-Nan Yang,Yue Song,Dongliang Zhan,Juan Wang,Leiting Li,Meisong Dai,Chao Gu,Yuezhi Wang,Daihu Shi,Xiaowei Wang,Huping Zhang,Liang Zeng,Danman Zheng,Chun-Lei Wang,Maoshan Chen,Guangbiao Wang,Xie Lin,Valpuri Sovero,Shoufeng Sha,Wenjiang Huang,S. L. Zhang,Mingyue Zhang,Jiangmei Sun,Linlin Xu,Yuan Li,Xing Liu,Qingsong Li,Jiahui Shen,Junyi Wang,Robert E. Paull,Jeffrey L. Bennetzen,Jun Wang,Shaoling Zhang +59 more
TL;DR: In this article, a high-quality draft genome sequence of the diploid P. bretschneideri Rehd was provided for de novo assembly of a highly heterozygous genome of this size with highly repetitive DNA sequences.
Journal ArticleDOI
Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor
Xun Xu,Yong Hou,Xuyang Yin,Li Bao,Aifa Tang,Luting Song,Fuqiang Li,Shirley Tsang,Kui Wu,Hanjie Wu,Weiming He,Liang Zeng,Manjie Xing,Renhua Wu,Hui Jiang,Xiao Liu,Dandan Cao,Guangwu Guo,Xueda Hu,Yaoting Gui,Zesong Li,Wenyue Xie,Xiaojuan Sun,Min Shi,Zhiming Cai,Zhiming Cai,Bin Wang,Meiming Zhong,Jingxiang Li,Zuhong Lu,Ning Gu,Xiuqing Zhang,Laurie Goodman,Lars Bolund,Jian Wang,Huanming Yang,Karsten Kristiansen,Michael Dean,Yingrui Li,Jun Wang +39 more
TL;DR: The pilot study demonstrates that ccRCC may be more genetically complex than previously thought and provides information that can lead to new ways to investigate individual tumors, with the aim of developing more effective cellular targeted therapies.
Journal ArticleDOI
Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations: a phase II efficacy and biomarker study
Yongchang Zhang,Lianxi Song,Liang Zeng,Yi Ping Xiong,Li Liu,Chunhua Zhou,Haiyan Yang,Zhan Wang,Qing Xia,Qinqin Xu,Nong Yang +10 more
TL;DR: The SUCCESS trial as discussed by the authors evaluated the efficacy of the combination therapy of sintilimab plus docetaxel and explored potential biomarkers for efficacy prediction for non-small cell lung cancer.
Journal ArticleDOI
Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations: a phase II efficacy and biomarker study
Yongchang Zhang,Lianxi Song,Liang Zeng,Yi Ping Xiong,Li Liu,Chunhua Zhou,Haiyan Yang,Zhan Wang,Qing Xia,Qinqin Xu,Nong Yang +10 more
TL;DR: The SUCCESS trial as mentioned in this paper evaluated the efficacy of the combination therapy of sintilimab plus docetaxel and explored potential biomarkers for efficacy prediction for non-small cell lung cancer.
Journal ArticleDOI
Investigation on the survival implications of PD-L1 expression status in ALK- rearranged advanced non-small cell lung cancer treated with first-line crizotinib.
TL;DR: In this article , the authors investigated the survival implication of baseline PD-L1 expression status in crizotinib-treated patients with ALK-rearranged advanced NSCLC.